RxDoctor Payments Data

Luke Monteagudo, MD

Internal Medicine · Minneapolis, MNNPI 1992187173

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 60th percentile of 1,924 internal medicine providers in Minnesota.

See all internal medicine providers in Minnesota

Medicare billing

Part B allowed, 2024
$593,322
Medicare patients
205
Services billed
40,520

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept27$204,696
Actemra ActpenTocilizumab44$187,139
Humira(Cf) PenAdalimumab26$182,366
ActemraTocilizumab45$176,850
Humira PenAdalimumab21$140,661
Hydroxychloroquine Sulfate107$5,715
MethotrexateMethotrexate Sodium124$3,873
Prednisone184$1,893
Colchicine16$1,206
Allopurinol55$1,136
Celecoxib11$948
Sulfasalazine22$882
Leflunomide13$781

Paid to pharmacies, not to this prescriber.

Other internal medicine in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →